The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

October 23, 2024 Kate Knibbs, Emily Mullin

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.

Previous Article
Microsoft Warns Foreign Disinformation Is Hitting the US Election From All Directions
Microsoft Warns Foreign Disinformation Is Hitting the US Election From All Directions

Russia, Iran, and China are targeting the US election with an evolving array of influence operations in the...

Next Article
Nigeria Drops Charges Against Tigran Gambaryan, Jailed Binance Exec and Former IRS Agent
Nigeria Drops Charges Against Tigran Gambaryan, Jailed Binance Exec and Former IRS Agent

After eight months, one of the US’s most prominent crypto-crime investigators may finally be coming home.